Latest Articles
Dostarlimab Boosts Long-Term Survival in Endometrial Cancer - Medscape
Dostarlimab Boosts Long-Term Survival in Endometrial Cancer Medscape
Published: June 22, 2026, 1 p.m.
Optical Biopsy Offers Non-Invasive Endometrial Cancer Detection - Technology Networks
Optical Biopsy Offers Non-Invasive Endometrial Cancer Detection Technology Networks
Published: June 22, 2026, 9:27 a.m.
Preetam Jain: Personalized Endometrial Cancer Treatment Based on 4 Key Molecular Subgroups - Oncodaily
Preetam Jain: Personalized Endometrial Cancer Treatment Based on 4 Key Molecular Subgroups Oncodaily
Published: June 22, 2026, 4:56 a.m.
Rectal endometriosis mimicking rectal cancer.
Published: June 22, 2026, midnight
The rising burden of endometrial cancer in Jamaica - Jamaica Observer
The rising burden of endometrial cancer in Jamaica Jamaica Observer
Published: June 21, 2026, 5:05 a.m.
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial - MSN
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial MSN
Published: June 21, 2026, 4:52 a.m.
Serum Interleukin-6 Levels in Endometriosis and Endometriosis-Associated Ovarian Cancer: A Systematic Review and Meta-Analysis Demonstrating a Biological Gradient.
This study quantifies serum/plasma interleukin-6 levels across the healthy-non-endometriosis benign-endometriosis-ovarian cancer spectrum, focusing on pooled geometric means stratified by control type.
Published: June 21, 2026, midnight
New NCCN Colorectal, Endometrial, Esophageal, and Gastric Cancer Guidlines Released - ICARE - Oncodaily
New NCCN Colorectal, Endometrial, Esophageal, and Gastric Cancer Guidlines Released - ICARE Oncodaily
Published: June 20, 2026, 5:02 p.m.
New NCCN Guidlines on Colorectal, Endometrial, Esophageal, and Gastric Cancer Released - ICARE - Oncodaily
New NCCN Guidlines on Colorectal, Endometrial, Esophageal, and Gastric Cancer Released - ICARE Oncodaily
Published: June 20, 2026, 5:02 p.m.
Dostarlimab Provides Long-Term Benefits in dMMR/MSI-H Endometrial Cancer - OncLive
Dostarlimab Provides Long-Term Benefits in dMMR/MSI-H Endometrial Cancer OncLive
Published: June 20, 2026, 1:04 p.m.
Link copied to clipboard!